Location History:
- Taejeon-si, KR (2009 - 2010)
- Daejeon, KR (2000 - 2013)
Company Filing History:
4 out of 321 
1 out of 2,169 
1 out of 3 Years Active: 2000-2013
Title: The Innovations of Og-Sung Moon
Introduction
Og-Sung Moon is a notable inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of cardiovascular diseases. With a total of 6 patents to his name, his work has the potential to impact many lives.
Latest Patents
One of his latest patents involves novel O-acyloxime derivatives, which are designed for the prevention and treatment of cardiovascular diseases. This invention highlights the excellent inhibitory effect of these derivatives on Lp-PLA, making them valuable for conditions such as hyperlipidemia, coronary arterial heart disease, atherosclerosis, and myocardial infarction. Another significant patent focuses on abietane diterpenoid compounds and their use in treating cardiovascular diseases, including hyperlipidemia and atherosclerosis. These compounds not only inhibit the oxidation of low-density lipoprotein (LDL) but also effectively reduce acyl-CoA: cholesterol acyltransferase (ACAT) activity.
Career Highlights
Og-Sung Moon has worked with prominent research institutions, including the Korea Research Institute of Bioscience and Biotechnology and the Korea Institute of Science and Technology. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical field.
Collaborations
Throughout his career, Og-Sung Moon has collaborated with esteemed colleagues such as Tae-Sook Jeong and Woo-Song Lee. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Og-Sung Moon's contributions to the field of cardiovascular treatment through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to pave the way for future advancements in pharmaceutical science.